1-9 of 9
Franz X. Schaub
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy

Open Access
Mario R. Fernandez, Franz X. Schaub, Chunying Yang, Weimin Li, Seongseok Yun, Stephanie K. Schaub, Frank C. Dorsey, Min Liu, Meredith A. Steeves, Andrea Ballabio, Alexandar Tzankov, Zhihua Chen, John M. Koomen, Anders E. Berglund, John L. Cleveland
Journal: Cancer Research
Cancer Res (2022) 82 (7): 1234–1250.
https://doi.org/10.1158/0008-5472.CAN-21-1168
Published: 01 April 2022
View articletitled, Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy
Open the PDF for Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic Anergy in another window
Includes: Supplementary data
Journal Articles

Abstract 818: Organoid based functional test to predict personalized treatment in cholangiocarcinoma

Free
Astrid Margossian, Franz X. Schaub, Annie Richardson, Michael Churchill, Rachele Rosati, Alexandra Dullea, G Adam Whitney, Hallie Swan, Robert Diaz, Lauren Appleyard, Vijaykrishna Gadi, Ali Zarrinpar, Milind Javle, Christopher Kemp, Shalini Pereira, Carla Grandori
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 818.
https://doi.org/10.1158/1538-7445.AM2020-818
Published: 15 August 2020
View articletitled, Abstract 818: Organoid based functional test to predict personalized treatment in cholangiocarcinoma
Journal Articles

Abstract 2625: Patient derived organoids to guide personalized neuroblastoma treatment

Free
Rachele Rosati, Hallie A. Swan, Laura Scolaro, Kateryna Krytska, John M. Maris, Franz X. Schaub, Carla Grandori
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2625.
https://doi.org/10.1158/1538-7445.AM2018-2625
Published: 01 July 2018
View articletitled, Abstract 2625: Patient derived organoids to guide personalized neuroblastoma treatment
Journal Articles

Abstract 1605: Personalization of cancer treatments with a CLIA-certified high-complexity and high-throughput drug sensitivity test

Free
Hallie A. Swan, Michael J. Churchill, Rachele Rosati, Franz X. Schaub, Reid C. Shaw, Roland M. Watt, Eduardo Mendez, Christopher J. Kemp, Vijayakrishna K. Gadi, Stephanie A. Murphy, Brady Bernard, Robert L. Diaz, Shalini C. Pereira, Carla Grandori
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 1605.
https://doi.org/10.1158/1538-7445.AM2018-1605
Published: 01 July 2018
View articletitled, Abstract 1605: Personalization of cancer treatments with a CLIA-certified high-complexity and high-throughput drug sensitivity test
Journal Articles

Abstract 582: Accelerating drug development with a CLIA approved functional test using patient derived organoids

Free
Franz X. Schaub, Michael J. Churchill, Hallie A. Swan, Rachele Rosati, Roland M. Watt, Reid C. Shaw, Stephanie A. Murphy, Robert L. Diaz, Shalini C. Pereira, Carla Grandori
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 582.
https://doi.org/10.1158/1538-7445.AM2018-582
Published: 01 July 2018
View articletitled, Abstract 582: Accelerating drug development with a CLIA approved functional test using patient derived organoids
Journal Articles

Abstract 1603: Patient derived tumor organoids identify actionable targets in heavily pretreated metastatic breast cancer patients

Free
Michael J. Churchill, Franz X. Schaub, Hallie A. Swan, Rachele Rosati, Fengting Yan, Reid C. Shaw, Kay E. Gurley, Robert L. Diaz, Shalini C. Pereira, Carla Grandori, Christopher J. Kemp, Vijayakrishna K. Gadi
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 1603.
https://doi.org/10.1158/1538-7445.AM2018-1603
Published: 01 July 2018
View articletitled, Abstract 1603: Patient derived tumor organoids identify actionable targets in heavily pretreated metastatic breast cancer patients
Journal Articles

Abstract 1619: Personalized medicine: A CLIA-certified high-throughput drug screening platform for ovarian cancer

Free
Hallie A. Swan, Rachele Rosati, Caroline Bridgwater, Michael J. Churchill, Roland M. Watt, Reid C. Shaw, Stephanie A. Murphy, Robert L. Diaz, Shalini C. Pereira, Franz X. Schaub, Carla Grandori
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 1619.
https://doi.org/10.1158/1538-7445.AM2018-1619
Published: 01 July 2018
View articletitled, Abstract 1619: Personalized medicine: A CLIA-certified high-throughput drug screening platform for ovarian cancer
Journal Articles

Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis

Free
Franz X. Schaub, Md. Shamim Reza, Colin A. Flaveny, Weimin Li, Adele M. Musicant, Sany Hoxha, Min Guo, John L. Cleveland, Antonio L. Amelio
Journal: Cancer Research
Cancer Res (2015) 75 (23): 5023–5033.
https://doi.org/10.1158/0008-5472.CAN-14-3538
Published: 30 November 2015
View articletitled, Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis
Open the PDF for Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis in another window
Includes: Multimedia, Supplementary data
Journal Articles

Abstract B9: Myc represses Ebf1 and Pax5 to impair early B-cell differentiation and drive progenitor B lymphomagenesis

Free
Franz X. Schaub, Chunying Yang, Weimin Li, Mark A. Hall, Lottie Peppers, Mohammad Fallahi, Joanne R. Doherty, John L. Cleveland
Journal: Cancer Research
Cancer Res (2011) 71 (18_Supplement): B9.
https://doi.org/10.1158/1538-7445.FBCR11-B9
Published: 28 October 2014
View articletitled, Abstract B9: Myc represses Ebf1 and Pax5 to impair early B-cell differentiation and drive progenitor B lymphomagenesis